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Introduction: Nasopharyngeal malignancy is one of the most frequent head and neck
cancers in adults, most often developing as an epithelial carcinoma, and is invariably present
by the time cervical lymphadenopathy develops. In this review, we document the frequency,
features, risk factors and histopathology of nasopharyngeal malignancy in adult Saudi adults
attending the Otolaryngology clinic.
Methods: Clinical history was taken from 100 individuals attending the Otolynryngology clinic.
This was followed by an examination, a CT scan and fiber-optic rhinoscopy to assess these
patients. When a nasopharyngeal mass was found, it was removed and sent for
histopathology and tissue diagnosis.
Results: 24% of the patients tested positive for a nasopharyngeal mass, resulting in a
frequency of 1.4 % in individuals with a nasopharyngeal mass with all sufferers being male.
Nasal obstruction, nasal discharge, headache/facial pain and enlargement of cervical lymph
nodes were most common clinical features
Conclusions: Nasopharyngeal malignancy was reveled in 6% of nasopharyngeal mass
sufferers with preponderance for the male gender.
Keywords: nasopharyngeal carcinoma, Saudi Arabia, Nasopharyngeal soft tissue mass

INTRODUCTION
The nasopharyngeal space being hidden allows for
significant spread of nasopharyngeal cancer before any
useful medical intervention is carried out. Ignorance of
the peculiar clinical features of nasopharyngeal cancer
allows for the spread of this disease to advanced stage
before presentation to the Otolaryngologist. [1]
Nasopharyngeal cancer (NPC) is very common in some
parts of the world. [2-4] its highest incidence has been
reported in an Asian country where it is the third most
common malignancy among men with an incidence rate
of between 15–50% in the general population. [4,5]
Among the Middle East countries, NPC is common in
Saudi Arabia, being ranked as most common head and
neck cancer and the 17th most common form of
cancer. [6] Another study from Saudi population
revealed that 22.5% of head and neck cancer was the
nasopharyngeal malignancy. [7] This is of great concern
as the secluded nature of the nasopharyngeal space and
practitioner ignorance of this aspect of the cancer allows
for significant cancerous spread before it is found and
any medical intervention can be carried out. The
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majority of NPC in adults is epithelial cancer, with
poorly differentiated squamous cell carcinoma,
undifferentiated nasopharyngeal carcinoma (also
known as lymphoepithelioma) and well-differentiated
squamous cell carcinoma. [8] Malignant lymphoma,
which is common in nasopharyngeal masses in
children, is rare in adults. [9] The current study was
performed to document the frequency, presenting
features, risk factors and histopathology of
nasopharyngeal malignancy in adult patients having
nasopharyngeal mass.

PATIENTS AND METHODS
It was a prospective study involving Adult patients > 20
years of age, attending the otolaryngology department
for their first visit were studied over a 2 years period as
nasopharyngeal mass below 20 years of age is of little or
no significance. [4] Those presenting a nasal obstruction
and undergoing an F.O. scope (for the first time) and CT
scan were included in the study. Clinical history was
taken and all F.O and CT scan findings were
documented so as to assess the presence or severity of
the nasopharyngeal mass. These scans were followed by
surgery to remove the mass and a sample of which was
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sent to a histopathology lab for tissue examination and
final diagnosis.

Square test or Fisher’s exact test. A t-testwas used to test
independent variables.

All demographic data, F.O. scope and CT scan findings
were analyzed with the help of Statistical Package for
Social Sciences (SPSS) version 17.0 by IBM Inc.,(USA).

RESULTS

Continuous variables were represented as a mean ±
standard deviation (SD) and were tested via a Chi

Of the 100 patients seen, 24 were diagnosed with
nasopharyngeal mass. Of these, 6 also had a
nasopharyngeal malignancy, giving a total frequency
for the condition of 6%. All 6 sufferers were male with a
mean age of 70.33 years as shown in Table 1.

Table 1 Demographic characteristics of study groups
Nasopharyngeal Malignancy
P value

Age

Present

Absent

70.33±7.09

37.87±13.94

0.0001

6
0

52
42

0.0380

Gender

-

Male
Female

The most common clinical features were nasal
obstruction
(100%),
nasal
discharge
(83.33%),
headache/facial pain (66.67%), enlargement of cervical
lymph nodes (50%) and nose bleeds (33.33%) as shown
in Table 2.

Table 2 Clinicopathological characteristics
patients with nasopharyngeal malignancy

of

Frequency

Percent

Clinical presentation

•

Nasal obstruction

6

100

•

Nasal discharge

5

83.33

•

Nasal bleed

2

33.33

•

Headache / facial pain

4

66.67

Cervical lymphadenopathy

3

50

•

Nasopharyngeal fullness

6

100

•

Infiltrating tumour

1

16.67

6

100

Neck Examination

•
CT Scan

F.O. scope

•

Nasopharyngeal mass

Histopathology
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•

Nasopharyngeal carcinoma

4

66.67

•

Malignant Lymphoma

2

33.33
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CT scans only identify infiltrating tumor with bony
erosion in 1 of the 6 patients suffering from the
malignancy (16.67%) and fiber-optic posterior
rhinoscopy could only detect the presence of a soft
tissue mass in the nasopharynx in all the six.
Histopathology tests diagnosed nasopharyngeal
carcinoma in 4 of the individuals (66%) and malignant
lymphoma in 2 (33%).

DISCUSSION
Cancer is usually considered to be a disease of the
industrialized world, whereas infectious diseases are
the main disease burden of the developing world [10]
The increase in life expectancy in most developing
countries, even in the least developed ones, together
with drastic changes in life style are expected to lead to
an epidemic of cancer in developing countries by the
next century. [11] The Middle East has witnessed
changes in the past 25 years. Rapid modernization and
its accompanying urbanization and westernization have
also been associated with changes in the pattern of
diseases, especially the incidence of cancer cases. [10]
NPC forms an important component of the head and
neck tumors although it is an uncommon cancer
worldwide [12] In Saudi Arabia, nasopharyngeal cancer
is the most common head and neck cancer, having an
approximate prevalence of 33%. [13] In the present
study we concentrated on the clinicopathological
presentation of nasopharyngeal carcinoma, to try and
determine the early signs of presentation so that
diagnosis and treatment can be made in a prompt and
efficient manner.
Results showed that all patients were male in their 60’s
and 70’s. This gender bias was not entirely unexpected
as male preponderance has been reported in various
studies [2,14,15] However it is also worth noting that
there have been studies that found a bimodal gender
distribution for nasopharyngeal carcinoma, but these
tended to be in younger sufferers, which were not
present in our study. [16]
Concerning the symptoms, some studies have shown
neck swelling to be the most common symptom of the
disease [15,16] but others, including ours, showed nasal
obstruction as the single most prevalent symptom. [17]
Epistaxis is also reported to be a common symptom, as a
result of blood vessel erosion by the growing tumor,
[18] as is cervical lymphadenopathy but again the
prevalence varies. One study in Malaysia found roughly
33% of suffers exhibited these symptoms, [19] which is
in agreement with our results. But another such study in
Nigeria showed a prevalence of over 90% for these
symptoms. [12] This serves to exemplify why the
variable signs and symptoms associated with
nasopharyngeal carcinoma are confounding and make
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diagnoses difficult until the disease has reached an
advanced stage.
Globally, about 50–90% of patients present with cervical
lymphadenopathy followed by nasal symptoms such as
epistaxis and nasal obstruction, otologic symptoms, and
neuro ophthalmic symptoms. [17,18]
Some rare manifestation for nasopharyngeal carcinoma
like
dermatomyositis,
pseudo
hypertrophicosteoarthropathy and diffuse lymphatic
infiltration has also been reported in literature. [19] Due
to the variable presentation of the disease and the
difficulty of access to the post nasal, the diagnosis of
nasopharyngeal is usually delayed or may be missed.
As early cases carry an excellent prognosis, attempts
should be made to make an early diagnosis so that
untoward complications can be avoided.

CONCLUSION
Nasopharyngeal malignancy constitutes 6% of
nasopharyngeal mass with its peak incidence in 6th and
7th decade and preponderance for male gender. Nasal
symptoms are most common presentation and
histopathology is mandatory in all cases. Cervical
lymphadenopathy followed by nasal symptoms such as
epistaxis, nasal obstruction, otologic symptoms, and
neuro ophthalmic symptoms are some of important
manifestations of NPC Some rare manifestation for
nasopharyngeal carcinoma like dermatomyositis,
pseudo hypertrophicosteoarthropathy and diffuse
lymphatic infiltration should also be kept in mind while
diagnosing NPC.
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